Nanjing Foster Pharmaceutical Co., Ltd. was established in 2003, and is now a leading company in the Chinese pharmaceutical industry, specializing in the development of “New Drugs” (the drugs that previously have not been marketed in China, i.e., New Chemical Entities) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.

Company production base covers an area of 100,000 sq meters. It composed by one pilot plant, 4 Multifunctional composite plants, one GMP Refined drying package workshop High pressure hydrogenation plant. The company is in compliance with GMP guidance, and iscertified with ISO9001:2000 and ISO14001, OHSAS18001.
?
We produce lots of API and relative pharmaceutical intermediates Such as Antineoplastic medicines (Lapatinib, ,Sunitinib, Dasatinib, Erlotinib), Anti-diabetic medicine(sitagliptin phosphate, Vildagliptin ) & other API and intermediate: Prasugrel, Agomelatine, Dronedarone, Etravirine, Ganciclovir, Valacyclovir Hydrochloride.etc
?
Holding up the philosophy that “Quality Technology and Service Foster Healthy Life,” Foster looks forward to establishing long-term, steady cooperative relationships with customers from around the globe.